State of New Jersey Common Pension Fund D’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
43,587
-3,884
-8% -$79.8K ﹤0.01% 1487
2026
Q1
$911K Buy
47,471
+61
+0.1% +$1.21K ﹤0.01% 1407
2025
Q4
$783K Sell
47,410
-92,253
-66% -$1.56M ﹤0.01% 1415
2025
Q3
$2.03M Buy
139,663
+1,783
+1% +$25.6K 0.01% 1308
2025
Q2
$1.93M Buy
137,880
+44,290
+47% +$623K 0.01% 1220
2025
Q1
$1.27M Buy
93,590
+7,347
+9% +$141K 0.01% 1455
2024
Q4
$1.76M Buy
86,243
+8,760
+11% +$224K 0.01% 1475
2024
Q3
$2.26M Sell
77,483
-25,613
-25% -$635K 0.01% 945
2024
Q2
$2.39M Sell
103,096
-61,979
-38% -$1.19M 0.01% 849
2024
Q1
$3.39M Buy
165,075
+28,475
+21% +$535K 0.01% 917
2023
Q4
$2.93M Buy
136,600
+29,511
+28% +$584K 0.01% 1077
2023
Q3
$2.21M Buy
107,089
+28,836
+37% +$731K 0.01% 1427
2023
Q2
$2.31M Hold
78,253
0.01% 1499
2023
Q1
$1.8M Hold
78,253
0.01% 1578
2022
Q4
$2.18M Hold
78,253
0.01% 1355
2022
Q3
$2.4M Sell
78,253
-13,645
-15% -$444K 0.01% 977
2022
Q2
$2.71M Buy
91,898
+14,967
+19% +$392K 0.01% 924
2022
Q1
$2.48M Buy
76,931
+17,313
+29% +$596K 0.01% 1388
2021
Q4
$2.66M Buy
59,618
+5,310
+10% +$252K 0.01% 1471
2021
Q3
$2.74M Buy
54,308
+3,448
+7% +$194K 0.01% 1256
2021
Q2
$3.99M Buy
50,860
+1,589
+3% +$98.3K 0.01% 860
2021
Q1
$2.81M Sell
49,271
-6,752
-12% -$452K 0.01% 1112
2020
Q4
$4.69M Sell
56,023
-16,136
-22% -$975K 0.02% 744
2020
Q3
$2.58M Sell
72,159
-11,717
-14% -$353K 0.01% 982
2020
Q2
$2.03M Buy
+83,876
New +$1.97M 0.01% 1389

Other funds holding DNLI

State of New Jersey Common Pension Fund D's DNLI Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Denali Therapeutics (DNLI) stake by 8.2% in Q2 2026, selling an estimated $79.8K and leaving 43,587 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

State of New Jersey Common Pension Fund D first reported a position in DNLI in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.69M in Q4 2020. 147 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 43,587 shares of Denali Therapeutics worth $1.12M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 3,884 Denali Therapeutics shares in Q2 2026, an estimated $79.8K.
  • Denali Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1487 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Denali Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • State of New Jersey Common Pension Fund D's Denali Therapeutics position peaked at $4.69M in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.